Prescription Medications, Brand Names Beginning with ‘Z’

Page 1 of 118 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

ZAFIRLUKAST

Zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. CONTRAINDICATIONS: Zafirlukast is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive…

AstraZeneca Pharmaceuticals LP5 October 2010

Zafirlukast

Avera McKennan Hospital28 March 2017

Zafirlukast

Par Pharmaceutical, Inc.6 November 2017

Zafirlukast

Zafirlukast tablets are indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. CONTRAINDICATIONS: Zafirlukast tablets are…

AvPAK7 June 2018

Zafirlukast

Zafirlukast tablets are indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. CONTRAINDICATIONS: Zafirlukast tablets are…

Carilion Materials Management2 January 2019

Page 1 of 118 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

FDA Medwatch

Precision Dose Inc. Issues Voluntary Nationwide Recall of Ranitidine Oral Solution, USP 150 mg/10 mL Due to Possible Presence of N-nitrosodimethylamine (NDMA) Impurity
Mon, 18 Nov 2019. Precision Dose Inc. is voluntarily recalling 5 lots of Ranitidine Oral Solution, USP 150 mg/10 mL to the consumer level. Ranitidine Oral Solution, USP 150 mg/10 mL, is being recalled because of potential N-Nitrosodimethylamine (NDMA) amounts above…
Update On Device Failure Associated with Getinge’s Maquet/Datascope Intra-Aortic Balloon Pumps – Letter to Health Care Providers
Mon, 18 Nov 2019. The U.S. Food and Drug Administration (FDA) is providing an update on our evaluation of device failures associated with Getinge's Maquet/Datascope intra-aortic balloon pump (IABP) devices: Cardiosave (Hybrid and Rescue), CS300 and CS100/CS100i.

RxDrugLabels

Medication Sections

Medication Information by RSS

About

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.